Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

PURPOSE: A multicenter phase II study was conducted to assess the efficacy of rituximab, methotrexate, procarbazine, and vincristine (R-MPV) followed by consolidation reduced-dose whole-brain radiotherapy (rdWBRT) and cytarabine in primary CNS lymphoma. PATIENTS AND METHODS: Patients received induct...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Oncol
Auteurs principaux: Morris, Patrick G., Correa, Denise D., Yahalom, Joachim, Raizer, Jeffrey J., Schiff, David, Grant, Barbara, Grimm, Sean, Lai, Rose K., Reiner, Anne S., Panageas, Kathy, Karimi, Sasan, Curry, Richard, Shah, Gaurav, Abrey, Lauren E., DeAngelis, Lisa M., Omuro, Antonio
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2013
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5569679/
https://ncbi.nlm.nih.gov/pubmed/24101038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.50.4910
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires